CANDACE HALL: Open Payments
NPI 1801412242 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,532 in 50 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $878 · 2025 $1,532
Food & beverage: $1,448Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $481 |
| ABBVIE INC. | 12 | $230 |
| Madrigal Pharmaceuticals | 6 | $182 |
| Lilly USA, LLC | 4 | $108 |
| Ethicon US, LLC | 1 | $94 |
| PFIZER INC. | 3 | $82 |
| Ardelyx, Inc. | 3 | $72 |
| Celltrion USA Inc. | 3 | $67 |
| GENZYME CORPORATION | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
Products named: TREMFYA, REZDIFFRA, OMVOH, RINVOQ, LINX REFLUX MANAGEMENT SYSTEM, IBSRELA, DUPIXENT, VEGZELMA.
Industry payments across VA — which companies pay providers there.
